4.3 Article

A Comparative Analysis and Review of lysyl Residues Affected by Post-translational Modifications

期刊

CURRENT GENOMICS
卷 16, 期 2, 页码 128-138

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389202916666150216221038

关键词

Acetylation; Lysine post-translational modifications; Methylation; Signaling; Sumoylation; Ubiquitylation

资金

  1. Associazione Italiana per la Ricerca sul Cancro, AIRC [IG10312]

向作者/读者索取更多资源

Post-translational modification is the most common mechanism of regulating protein function. If phosphorylation is considered a key event in many signal transduction pathways, other modifications must be considered as well. In particular the side chain of lysine residues is a target of different modifications; notably acetylation, methylation, ubiquitylation, sumoylation, neddylation, etc. Mass spectrometry approaches combining highly sensitive instruments and specific enrichment strategies have enabled the identification of modified sites on a large scale. Here we make a comparative analysis of the most representative lysine modifications (ubiquitylation, acetylation, sumoylation and methylation) identified in the human proteome. This review focuses on conserved amino acids, secondary structures preference, subcellular localization of modified proteins, and signaling pathways where these modifications are implicated. We discuss specific differences and similarities between these modifications, characteristics of the crosstalk among lysine post translational modifications, and single nucleotide polymorphisms that could influence lysine post-translational modifications in humans.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Contribution of the CK2 Catalytic Isoforms α and α' to the Glycolytic Phenotype of Tumor Cells

Francesca Zonta, Christian Borgo, Camila Paz Quezada Meza, Ionica Masgras, Andrea Rasola, Mauro Salvi, Lorenzo A. Pinna, Maria Ruzzene

Summary: CK2, an overexpressed Ser/Thr protein kinase in many cancers, plays a crucial role in the uncontrolled proliferation, motility, and survival of cancer cells. This study reveals that both CK2 alpha and alpha' isoforms contribute to cell proliferation, survival, and tumorigenicity, with a prominent role for CK2 alpha in tumor metabolism.
Article Chemistry, Medicinal

Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach

Christian Borgo, Luca Cesaro, Tsuyoshi Hirota, Keiko Kuwata, Claudio D'Amore, Thomas Ruppert, Renata Blatnik, Mauro Salvi, Lorenzo A. Pinna

Summary: CK2, a protein kinase with pleiotropic functions, is implicated in global human pathologies, particularly cancer. Selective inhibitors like CX4945 and GO289 show promise in controlling the CK2-dependent phosphoproteome.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Editorial Material Biochemistry & Molecular Biology

Editorial of Special Issue Protein Post-Translational Modifications in Signal Transduction and Diseases

Claudio D'Amore, Mauro Salvi

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

How can a traffic light properly work if it is always green? The paradox of CK2 signaling

Christian Borgo, Claudio D'Amore, Luca Cesaro, Stefania Sarno, Lorenzo A. Pinna, Maria Ruzzene, Mauro Salvi

Summary: CK2 is a constitutively active protein kinase that plays a crucial role in maintaining phosphorylation levels for various substrates, supporting important biological functions. However, its activity must be carefully regulated to prevent pathological consequences, especially in diseases like cancer, chronic inflammation, and neurodegeneration. Understanding the regulation of CK2 is essential for potential therapeutic interventions in related diseases.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2021)

Article Respiratory System

A mutational approach to dissect the functional role of the putative CFTR PTM-CODE

Claudio D'Amore, Christian Borgo, Mauro Salvi

Summary: The functional recovery of F508del-CFTR is related to the post-translational modifications (PTMs) of CFTR, but regulating the PTM code is not essential for therapeutic approaches.

JOURNAL OF CYSTIC FIBROSIS (2021)

Article Cell Biology

Targeting CK2 in cancer: a valuable strategy or a waste of time?

Mauro Salvi, Christian Borgo, Lorenzo A. Pinna, Maria Ruzzene

Summary: The newly developed compound SGC-CK2-1, which is more selective than other CK2 inhibitors, has shown poor efficacy in reducing cell growth in different cancer cell lines, raising questions about the anticancer efficacy of CX-4945, the commonly used clinical-grade CK2 inhibitor.

CELL DEATH DISCOVERY (2021)

Article Biochemistry & Molecular Biology

Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants

Christian Borgo, Claudio D'Amore, Valeria Capurro, Valeria Tomati, Elvira Sondo, Federico Cresta, Carlo Castellani, Nicoletta Pedemonte, Mauro Salvi

Summary: The advent of Trikafta has revolutionized the treatment of cystic fibrosis patients with the most common misfolding mutation, F508del-CFTR. However, there is still room for improvement in its efficacy, especially in rare CFTR mutations. By targeting the misfolding detection machinery, the combination of Trikafta with a drug like TAK-243 shows promising results in improving CFTR function, including in rare CF-causing mutations.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Biochemistry & Molecular Biology

KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR

Claudio D'Amore, Christian Borgo, Valentina Bosello Travain, Mauro Salvi

Summary: Cystic fibrosis is a genetic disease caused by mutations in the CFTR gene, which encodes a chloride ion channel responsible for regulating chloride transport. Recent research has identified post-translational modifications of CFTR and suggested modulating these modifications as a potential therapeutic strategy. Using a siRNA library, we identified enzymes whose downregulation increases the stability and function of the F508del-CFTR mutant.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Multidisciplinary

Development of small cyclic peptides targeting the CK2α/β interface

Eleanor L. Atkinson, Jessica Iegre, Claudio D'Amore, Paul Brear, Mauro Salvi, Marko Hyvonen, David R. Spring

Summary: In this study, an iterative cycle of enzymatic assays, X-ray crystallography, molecular modelling and cellular assays was used to develop a functionalisable chemical probe for the investigation of CK2α/β PPI. The lead peptide, P8C9, showed successful binding to CK2α at the PPI site, and it was found to be easily synthesizable and functionalisable. The peptide also exhibited high stability in serum and had potential for further optimization.

CHEMICAL COMMUNICATIONS (2022)

暂无数据